A new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn’t seen major drug advances in over a decade, researchers reported Monday. Results from the study, presented at the
AFP
The News You Need, Delivered To You.
Subscribe to the Guardian today and never miss the stories that shape your Business